Oxcarbazepine
Product Images NDC 70518-4507

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 70518-4507). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This is a description of Oxcarbazepine Tablet in 300 mg strength with a quantity of 30 tablets. The tablets are repackaged by RemedyRepack Inc. in Indiana, PA and manufactured by Breckenridge in Boca Raton, FL. The usual dosage instructions can be found in the insert provided. The tablets are oval, brown in color, and are to be stored at 20-25°C (68-77°F). It is a prescription medication and should be kept out of the reach of children.*

FDA Label Image

Chemical Structure (Oxcarbazepine 01)

FDA Label Image

Figure 1 (Oxcarbazepine 02)

This text provides information about the exit rate for a study comparing Oxcarbazepine with Placebo using a log-rank test. The p-value calculated for the comparison is 0.0001, suggesting a significant difference between the two groups. The data also shows the time on trial from Day 2 for different days and the treatment groups being compared.*

FDA Label Image

Figure 2 (Oxcarbazepine 03)

This text provides information on the seizure rate analysis using a log-rank test, with a p-value of 0.046. It also includes a table showing the days from the first dose to the first seizure for the treatment groups of Oxcarbazepine and Placebo.*

FDA Label Image

Figure 3 (Oxcarbazepine 04)

This text provides information about the exit rate analysis, including the results of the log-rank test with a p-value of 0.0001. The graph shows the time to exit in days for two treatment groups, labeled as HIGH and LOW.*

FDA Label Image

Figure 4 (Oxcarbazepine 05)

This is a statistical output related to the "Exit rate" analysis. The log-rank test was performed, resulting in a p-value of 0.0001, indicating significant differences in exit rates between groups. The graph displays the time to exit in days, with a treatment group denoted as "Grot - HIGH ow".*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.